Stocktoria

Editas Medicine, Inc. EDIT

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2016-02-03 · LEI

Editas Medicine, Inc. institutional holders

InvestorSharesValue% of company
BlackRock Finance, Inc.7,782,517$36.3M7.95%
RENAISSANCE TECHNOLOGIES LLC3,972,160$9.8M4.06%
D. E. Shaw & Co., Inc.1,943,893$4.8M1.99%
TWO SIGMA INVESTMENTS, LP1,549,063$3.8M1.58%
AQR CAPITAL MANAGEMENT LLC1,370,497$3.4M1.4%
CITADEL ADVISORS LLC875,789$2.2M0.89%
Point72 Asset Management, L.P.116,995$288,9780.12%

% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.